Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

504 trials with published results (27%)

Research Maturity

1428 completed trials (77% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.3%

99 terminated out of 1866 trials

Success Rate

93.5%

+6.9% vs benchmark

Late-Stage Pipeline

33%

614 trials in Phase 3/4

Results Transparency

35%

504 of 1428 completed with results

Key Signals

504 with results94% success99 terminated

Data Visualizations

Phase Distribution

1,626Total
Not Applicable (502)
Early P 1 (15)
P 1 (280)
P 2 (215)
P 3 (336)
P 4 (278)

Trial Status

Completed1,428
Unknown203
Terminated99
Recruiting48
Not Yet Recruiting30
Active Not Recruiting26

Trial Success Rate

93.5%

Benchmark: 86.6%

Based on 1428 completed trials

Clinical Trials (1866)

Showing 20 of 20 trials
NCT07854990Not Yet RecruitingPrimary

Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes

NCT07112872Phase 2Active Not RecruitingPrimary

A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes

NCT07847177Not ApplicableCompletedPrimary

Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes

NCT03449251Phase 2Active Not Recruiting

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

NCT06156696CompletedPrimary

A Study to Compare the Use of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Addition to Daily Practice and Treatment With Daily Practice and Treatment Alone in Patients With Type 2 Diabetes Mellitus

NCT07137585Phase 1Active Not RecruitingPrimary

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity

NCT07847112Not Yet RecruitingPrimary

Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications

NCT07847099Not Yet RecruitingPrimary

Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications

NCT06704672Not ApplicableRecruiting

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT07835360Recruiting

Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes

NCT07197788Not ApplicableEnrolling By InvitationPrimary

Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

NCT06608212Completed

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

NCT07833813Not ApplicableNot Yet RecruitingPrimary

Incretin Therapy and Exercise in Type 2 Diabetes

NCT00814372Phase 2TerminatedPrimary

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

NCT07743450Phase 3Recruiting

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

NCT07807059Phase 1Recruiting

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

NCT07351058Phase 3Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT07809477Not ApplicableNot Yet RecruitingPrimary

Integrated Diabetes and Oral Health Care in Oman

NCT07662213Phase 3RecruitingPrimary

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

NCT06208189Not ApplicableActive Not Recruiting

Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose

Scroll to load more

Research Network

Activity Timeline